Role of SHP-1, Kv.1.2, and cGMP in nitric oxide-induced ERK1/2 MAP kinase dephosphorylation in rat vascular smooth muscle cells

Cardiovascular Research

Volumn 68, Issue 2, 2005, Pages 268-277

  Palen, Desiree I ^a   Belmadani, Souad ^b   Lucchesi, Pamela A ^a   Matrougui, Khalid ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cGMP; ERK1 2 MAP kinase; Kv.1.2 potassium channel; Nitric oxide; Relaxation; Tyrosine phosphatase SHP 1

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; AM 92016; CROMAKALIM; CYCLIC GMP; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N ACETYL S NITROSOPENICILLAMINE; NITROPRUSSIDE SODIUM; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; PROTEIN SH2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHEMICAL INTERACTION; CONTROLLED STUDY; DEPHOSPHORYLATION; ENZYME ACTIVATION; ENZYME REGULATION; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA, THORACIC; BLOTTING, WESTERN; CELLS, CULTURED; CROMAKALIM; CYCLIC GMP; ENZYME INHIBITORS; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KV1.2 POTASSIUM CHANNEL; MALE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROPRUSSIDE; OKADAIC ACID; PENICILLAMINE; PHOSPHORYLATION; PROTEIN-TYROSINE-PHOSPHATASE; RATS; RATS, SPRAGUE-DAWLEY; SHP1 PROTEIN TYROSINE PHOSPHATASE; VASODILATOR AGENTS;

EID: 26444590429     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2005.05.031     Document Type: Article

References (31)

1. T.M. Lincoln, and H. Dey NandSellak Invited review: cGMP-dependent protein kinase signaling mechanisms in smooth muscle: from the regulation of tone to gene expression J Appl Physiol 91 2001 1421 1430
2. T.M. Lincoln, N.B. Dey, N.J. Boerth, T. Cornwell, and G.A. LandSoff Nitric oxide-cyclic GMP pathway regulates vascular smooth muscle cell phenotypic modulation: implications in vascular diseases Acta Physiol Scand 164 1998 507 515
3. I.N. Bratz, R. Falcon, L.D. Partridge, and N.L. Kanagy Vascular smooth muscle cell membrane depolarization after NOS inhibition hypertension Am J Physiol Heart Circ Physiol 282 2002 H1648 H1655
4. F.M. Faraci, and D.D. Heistad Regulation of the cerebral circulation: role of endothelium and potassium channels Physiol Rev 78 1998 53 97
5. E.D. Michelakis, H.L. Reeve, J.M. Huang, S. Tolarova, D.P. Nelson, and E.K. Weir Potassium channel diversity in vascular smooth muscle cells Can J Physiol Pharmacol 75 1997 889 897
6. S. Albarwani, L.T. Nemetz, J.A. Madden, A.A. Tobin, S.K. England, and P.F. Pratt Voltage-gated K+ channels in rat small cerebral arteries: molecular identity of the functional channels J Physiol 551 2003 751 763
7. E. Takahashi, and B.C. Berk MAP kinases and vascular smooth muscle function Acta Physiol Scand 164 1998 611 621
8. K. Matrougui, L.B. Tanko, L. Loufrani, D. Gorny, B.I. Levy, and A. Tedgui Involvement of Rho-kinase and the actin filament network in angiotensin II-induced contraction and extracellular signal-regulated kinase activity in intact rat mesenteric resistance arteries Arterioscler Thromb Vasc Biol 21 2001 1288 1293
9. R.M. Touyz, G. Hes, X.H. Wu, J.B. Park, M.E. Mabrouk, and E.L. Schiffrin Src is an important mediator of extracellular signal-regulated kinase 1/2-dependent growth signaling by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients Hypertension 38 2001 56 64
10. K. Matrougui, Y.E. Eskildsen-Helmond, A. Fiebeler, D. Henrion, B.I. Levy, and A. Tedgui Angiotensin II stimulates extracellular signal-regulated kinase activity in intact pressurized rat mesenteric resistance arteries Hypertension 36 2000 617 621
11. F.M. Martens, B. Demeilliers, D. Girardot, C. Daigle, H.H. Dao, and D. deBlois Vessel-specific stimulation of protein synthesis by nitric oxide synthase inhibition: role of extracellular signal-regulated kinases 1/2 Hypertension 39 2002 16 21
12. T. Kubo, H. Hosokawa, T. Kambe, and R. Fukumori Angiotensin II mediates pressure loading-induced mitogen-activated protein kinase activation in isolated rat aorta Eur J Pharmacol 391 2000 281 287
13. N. Sreejayan, Y. Lin, and A. Hassid NO attenuates insulin signaling and motility in aortic smooth muscle cells via protein tyrosine phosphatase 1B-mediated mechanism Arterioscler Thromb Vasc Biol 22 2002 1086 1092
14. Y. Lin, A.C. Ceacareanu, and A. Hassid Nitric oxide-induced inhibition of aortic smooth muscle cell motility: role of PTP-PEST and adaptor proteins p130cas and Crk Am J Physiol Heart Circ Physiol 285 2003 H710 H721
15. Y. Chang, B. Ceacareanu, M. Dixit, N. Sreejayan, and A. Hassid Nitric oxide-induced motility in aortic smooth muscle cells: role of protein tyrosine phosphatase SHP-2 and GTP-binding protein Rho Circ Res 91 2002 390 397
16. Y. Takeda-Matsubara, H. Nakagami, M. Iwai, T.X. Cui, T. Shiuchi, and M. Akishita Estrogen activates phosphatases and antagonizes growth-promoting effect of angiotensin: II Hypertension 39 2002 41 45
17. M.J. Hagerty, C.L. Wainwright, and K.A. Kane The in vivo cardiovascular effects of a putative class III anti-arrhythmic drug, AM 92016 J Pharm Pharmacol 48 1996 417 421
18. A. Sabri, G. Govindarajan, T.M. Griffin, K.L. Byron, A.M. Samarel, and P.A. Lucchesi Calcium- and protein kinase C-dependent activation of the tyrosine kinase PYK2 by angiotensin II in vascular smooth muscle Circ Res 83 1998 841 851
19. P.A. Lucchesi, J.M. Bell, L.S. Willis, K.L. Byron, M.A. Corson, and B.C. Berk Ca(2+)-dependent mitogen-activated protein kinase activation in spontaneously hypertensive rat vascular smooth muscle defines a hypertensive signal transduction phenotype Circ Res 78 1996 962 970
20. P.A. Lucchesi, A. Sabri, S. Belmadani, and K. Matrougui Involvement of metalloproteinases 2/9 in epidermal growth factor receptor transactivation in pressure-induced myogenic tone in mouse mesenteric resistance arteries Circulation 110 2004 3587 3593
21. T.L. Cornwell, and T.M. Lincoln Regulation of intracellular Ca2+ levels in cultured vascular smooth muscle cells. Reduction of Ca2+ by atriopeptin and 8-bromo-cyclic GMP is mediated by cyclic GMP-dependent protein kinase J Biol Chem 264 1989 1146 1155
22. D. Hattan, E. Nesti, T.G. Cachero, and A.D. Morielli Tyrosine phosphorylation of Kv1.2 modulates its interaction with the actin-binding protein cortactin J Biol Chem 277 2002 38596 38606
23. K.L. Byron, and P.A. Lucchesi Signal transduction of physiological concentrations of vasopressin in A7r5 vascular smooth muscle cells. A role for PYK2 and tyrosine phosphorylation of K+ channels in the stimulation of Ca2+ spiking J Biol Chem 277 2002 7298 7307
24. Z.S. Katusic, J.T. Shepherd, and P.M. Vanhoutte Vasopressin causes endothelium-dependent relaxations of the canine basilar artery Circ Res 55 1984 575 579
25. G.S. Dhaunsi, C. Matthews, K. Kaur, and A. Hassid NO increases protein tyrosine phosphatase activity in smooth muscle cells: relationship to antimitogenesis Am J Physiol 272 1997 H1342 H1349
26. A. Hassid, J. Yao, and S. Huang NO alters cell shape and motility in aortic smooth muscle cells via protein tyrosine phosphatase 1B activation Am J Physiol 277 1999 H1014 H1026
27. K. Matrougui, J. Maclouf, B.I. Levy, and D. Henrion Impaired nitric oxide- and prostaglandin-mediated responses to flow in resistance arteries of hypertensive rats Hypertension 30 1997 942 947
28. A. Koller, and A. Huang Impaired nitric oxide-mediated flow-induced dilation in arterioles of spontaneously hypertensive rats Circ Res 74 1994 416 421
29. H.Y. Qiu, D. Henrion, J. Benessiano, C. Heymes, B. Tournier, and B.I. Levy Decreased flow-induced dilation and increased production of cGMP in spontaneously hypertensive rats Hypertension 32 1998 1098 1103
30. G.J. Lagaud, E. Lam, A. Lui, C. van Breemen, and I. Laher Nonspecific inhibition of myogenic tone by PD98059, a MEK1 inhibitor, in rat middle cerebral arteries Biochem Biophys Res Commun 257 1999 523 527
31. T.A. Khan, C. Bianchi, M. Ruel, P. Voisine, J. Li, and J.R. Liddicoat Mitogen-activated protein kinase inhibition and cardioplegia-cardiopulmonary bypass reduce coronary myogenic tone Circulation 108 Supp 1 2003 II348 II353